- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.75 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.2: 4 residues within 4Å:- Chain A: T.190, L.227, N.230, Y.234
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.230
NAG.3: 1 residues within 4Å:- Chain A: N.211
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.211
NAG.4: 3 residues within 4Å:- Chain A: S.236, G.237, N.241
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.241
NAG.5: 1 residues within 4Å:- Chain A: N.201
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.201
NAG.13: 4 residues within 4Å:- Chain C: T.190, L.227, N.230, Y.234
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.230
NAG.14: 1 residues within 4Å:- Chain C: N.211
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.211
NAG.15: 3 residues within 4Å:- Chain C: S.236, G.237, N.241
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.241
NAG.16: 1 residues within 4Å:- Chain C: N.201
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.201
NAG.24: 4 residues within 4Å:- Chain E: T.190, L.227, N.230, Y.234
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.230
NAG.25: 1 residues within 4Å:- Chain E: N.211
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.211
NAG.26: 3 residues within 4Å:- Chain E: S.236, G.237, N.241
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.241
NAG.27: 1 residues within 4Å:- Chain E: N.201
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.201
- 15 x GOL: GLYCEROL(Non-functional Binders)
GOL.6: 6 residues within 4Å:- Chain A: E.93, C.94, L.95, P.96, D.123, R.145
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:D.123, A:R.145
- Water bridges: A:A.97
GOL.7: 5 residues within 4Å:- Chain A: G.47, V.48, A.49, T.50, D.51
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:T.50, A:T.50, A:D.51, A:D.51, A:D.51
GOL.8: 6 residues within 4Å:- Chain A: R.220, F.221, T.222, F.225, P.252, E.253
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:R.220, A:T.222, A:P.252
GOL.10: 3 residues within 4Å:- Chain A: S.19, V.21
- Chain B: Q.94
5 PLIP interactions:2 interactions with chain B, 3 interactions with chain A- Hydrogen bonds: B:K.87, A:S.5, A:S.19, A:S.19
- Water bridges: B:Q.94
GOL.11: 6 residues within 4Å:- Chain B: N.62, E.63, T.65, Q.66
- Chain F: W.30
- Ligands: NAG-NAG-BMA-MAN-MAN.1
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:N.62, B:N.62, B:E.63, B:T.65, B:Q.66
GOL.17: 6 residues within 4Å:- Chain C: E.93, C.94, L.95, P.96, D.123, R.145
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:D.123, C:R.145
- Water bridges: C:A.97
GOL.18: 5 residues within 4Å:- Chain C: G.47, V.48, A.49, T.50, D.51
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:T.50, C:T.50, C:D.51, C:D.51, C:D.51
GOL.19: 6 residues within 4Å:- Chain C: R.220, F.221, T.222, F.225, P.252, E.253
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:R.220, C:T.222, C:P.252
GOL.21: 3 residues within 4Å:- Chain C: S.19, V.21
- Chain D: Q.94
5 PLIP interactions:2 interactions with chain D, 3 interactions with chain C- Hydrogen bonds: D:K.87, C:S.5, C:S.19, C:S.19
- Water bridges: D:Q.94
GOL.22: 6 residues within 4Å:- Chain B: W.30
- Chain D: N.62, E.63, T.65, Q.66
- Ligands: NAG-NAG-BMA-MAN-MAN.12
5 PLIP interactions:5 interactions with chain D- Hydrogen bonds: D:N.62, D:N.62, D:E.63, D:T.65, D:Q.66
GOL.28: 6 residues within 4Å:- Chain E: E.93, C.94, L.95, P.96, D.123, R.145
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:D.123, E:R.145
- Water bridges: E:A.97
GOL.29: 5 residues within 4Å:- Chain E: G.47, V.48, A.49, T.50, D.51
5 PLIP interactions:5 interactions with chain E- Hydrogen bonds: E:T.50, E:T.50, E:D.51, E:D.51, E:D.51
GOL.30: 6 residues within 4Å:- Chain E: R.220, F.221, T.222, F.225, P.252, E.253
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:R.220, E:T.222, E:P.252
GOL.32: 3 residues within 4Å:- Chain E: S.19, V.21
- Chain F: Q.94
5 PLIP interactions:3 interactions with chain E, 2 interactions with chain F- Hydrogen bonds: E:S.5, E:S.19, E:S.19, F:K.87
- Water bridges: F:Q.94
GOL.33: 6 residues within 4Å:- Chain D: W.30
- Chain F: N.62, E.63, T.65, Q.66
- Ligands: NAG-NAG-BMA-MAN-MAN.23
5 PLIP interactions:5 interactions with chain F- Hydrogen bonds: F:N.62, F:N.62, F:E.63, F:T.65, F:Q.66
- 3 x KHG: (1S,3R,5R,7S)-N-(trans-4-aminocyclohexyl)-3-methyl-5-phenyltricyclo[3.3.1.1~3,7~]decane-1-carboxamide(Non-covalent)
KHG.9: 10 residues within 4Å:- Chain A: R.37, V.39, G.40, L.41, A.74, G.75, L.159
- Chain B: L.14, Y.16, M.47
9 PLIP interactions:4 interactions with chain B, 5 interactions with chain A- Hydrophobic interactions: B:L.14, B:Y.16, B:Y.16, B:Y.16, A:V.39, A:V.39, A:L.41, A:A.74
- Hydrogen bonds: A:R.37
KHG.20: 10 residues within 4Å:- Chain C: R.37, V.39, G.40, L.41, A.74, G.75, L.159
- Chain D: L.14, Y.16, M.47
9 PLIP interactions:4 interactions with chain D, 5 interactions with chain C- Hydrophobic interactions: D:L.14, D:Y.16, D:Y.16, D:Y.16, C:V.39, C:V.39, C:L.41, C:A.74
- Hydrogen bonds: C:R.37
KHG.31: 10 residues within 4Å:- Chain E: R.37, V.39, G.40, L.41, A.74, G.75, L.159
- Chain F: L.14, Y.16, M.47
9 PLIP interactions:4 interactions with chain F, 5 interactions with chain E- Hydrophobic interactions: F:L.14, F:Y.16, F:Y.16, F:Y.16, E:V.39, E:V.39, E:L.41, E:A.74
- Hydrogen bonds: E:R.37
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Plewe, M.B. et al., Discovery of Adamantane Carboxamides as Ebola Virus Cell Entry and Glycoprotein Inhibitors. Acs Med.Chem.Lett. (2020)
- Release Date
- 2019-12-11
- Peptides
- Envelope glycoprotein,Envelope glycoprotein,Envelope glycoprotein: ACE
Envelope glycoprotein: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.75 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 15 x GOL: GLYCEROL(Non-functional Binders)
- 3 x KHG: (1S,3R,5R,7S)-N-(trans-4-aminocyclohexyl)-3-methyl-5-phenyltricyclo[3.3.1.1~3,7~]decane-1-carboxamide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Plewe, M.B. et al., Discovery of Adamantane Carboxamides as Ebola Virus Cell Entry and Glycoprotein Inhibitors. Acs Med.Chem.Lett. (2020)
- Release Date
- 2019-12-11
- Peptides
- Envelope glycoprotein,Envelope glycoprotein,Envelope glycoprotein: ACE
Envelope glycoprotein: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B